Results 131 to 140 of about 22,540 (195)

Methodological concerns regarding "Use of high-dose steroid therapy: addition of anakinra in the treatment of severe COVID-19". [PDF]

Rev Assoc Med Bras (1992)
Yıldırım F.
europepmc   +1 more source

Prophylactic Anakinra to Prevent Neurotoxicity After CAR T-Cell Therapy in Aggressive B-Cell Lymphomas: A Single-Center Real-World Experience. [PDF]

Cancers (Basel)
Schmid T, Shaforostova I, Bacher U, Seipel K, Kronig MN, Pabst T.   +5 more
europepmc   +1 more source

A 24-Year-Old Man with Disseminated Tuberculosis and A Corticosteroid-Refractory Paradoxical Reaction to Anti-Tuberculous Treatment. [PDF]

Eur J Case Rep Intern Med
Charalampidis C, Karantana V, Kavatha D, Tsiodras S, Thomas K.   +4 more
europepmc   +1 more source

Anakinra for tocilizumab-refractory febrile infection-related epilepsy syndrome with normal IL-1β levels: a case report. [PDF]

Front Immunol
Zhang L, Li D, Wang J, Wang X, Zhao W, Lu G.   +5 more
europepmc   +1 more source

Envenomation-Induced Hemophagocytic Lymphohistiocytosis (HLH): First Reported Adult Case Following A Spider Bite. [PDF]

Eur J Case Rep Intern Med
Baik J, Khajar F, Hughes N, Usman M.
europepmc   +1 more source

Idiopathic recurrent pericarditis in children: a tertiary care cohort highlighting the emergence and effectiveness of interleukin-1 blockade. [PDF]

Eur J Pediatr
Gunalp A, Akay N, Kirali M, Torunoglu Z, Aslan E, Gul U, Konte EK, Senturk NGK, Yildiz M, Haslak F, Adrovic A, Sahin S, Barut K, Dedeoglu R, Kasapcopur O.   +14 more
europepmc   +1 more source

Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra. [PDF]

Front Immunol
Amikishiyev S, Deniz R, Gunver MG, Aghamuradov S, Koca N, Ince B, Bektas M, Yilmaz A, Canturk Y, Durak G, Kose M, Erelel M, Çağatay AA, Yavuz SS, Kalayoglu Besisik S, Esen F, Gül A.   +16 more
europepmc   +1 more source

Anakinra for intravenous immunoglobulin-resistant Kawasaki disease: a systematic literature review. [PDF]

RMD Open
Matucci-Cerinic C, Alunno A, Schoones JW, Gattorno M, Koné-Paut I, Dusser P.   +5 more
europepmc   +1 more source

Respiratory effects of off label anakinra in critically ill neonates: a 15-patient observational cohort study. [PDF]

Front Pediatr
De Rose DU, Cesaroni GM, Campi F, Maddaloni C, Ronci S, Caoci S, Capolupo I, Dotta A.   +7 more
europepmc   +1 more source

Canakinumab dosing intervals in pediatric colchicine-resistant FMF: outcomes and predictors of successful extension in a real-world cohort. [PDF]

Rheumatology (Oxford)
Akay N, Barut K, Kosa B, Mert EN, Torunoglu Z, Aslan E, Gul U, Kilic Konte E, Yildiz M, Sahin S, Kasapcopur O.   +10 more
europepmc   +1 more source